Literature DB >> 7607352

The effect of diabetic control on diabetic retinopathy.

E M Kohner1.   

Abstract

Poor diabetic control is associated with an increased risk of diabetic retinopathy, and there is a particularly increased risk in insulin-dependent (type 1) patients for the development of proliferative diabetic retinopathy. There is good evidence that hyperperfusion is an important factor in the evolution of diabetic retinopathy. This hyperperfusion is worse in those with poor diabetic control. The increased blood flow associated with high glucose interferes with autoregulation, and this further increases flow, damaging the endothelial lining of the blood vessels and leading to worsening of the retinopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7607352     DOI: 10.1038/eye.1993.66

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.

Authors:  Christian Ott; Agnes Jumar; Kristina Striepe; Stefanie Friedrich; Marina V Karg; Peter Bramlage; Roland E Schmieder
Journal:  Cardiovasc Diabetol       Date:  2017-02-23       Impact factor: 9.951

2.  Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.

Authors:  Christian Ott; Ulrike Raff; Stephanie Schmidt; Iris Kistner; Stefanie Friedrich; Peter Bramlage; Joanna M Harazny; Roland E Schmieder
Journal:  Cardiovasc Diabetol       Date:  2014-01-14       Impact factor: 9.951

3.  Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study.

Authors:  Yoo-Ri Chung; Kyoung Hwa Ha; Kihwang Lee; Dae Jung Kim
Journal:  PLoS One       Date:  2019-10-28       Impact factor: 3.240

4.  Association between interarm blood pressure differences and diabetic retinopathy in patients with type 2 diabetes.

Authors:  Ji Hyun Lee; Ye An Kim; Young Lee; Woo-Dae Bang; Je Hyun Seo
Journal:  Diab Vasc Dis Res       Date:  2020 Jul-Aug       Impact factor: 3.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.